The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery

American Journal of Ophthalmology

Volumn 131, Issue 3, 2001, Pages 293-300

  Soto, Antonio Mendívil ^a,b   Mendívil, María P ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BALANCED SALT SOLUTION; BSS PLUS; CYCLOPENTOLATE; DEXAMETHASONE ACETATE; FLUDROCORTISONE; GENTADEXA; GENTAMICIN; GRAMICIDIN; HYALURONIC ACID; NEOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBUPROCAINE; PHENYLEPHRINE; PLACEBO; POVIDONE IODINE; TETRACAINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ACCURACY; ADULT; ANTERIOR EYE CHAMBER; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CATARACT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG STABILITY; DRUG TISSUE LEVEL; ENDOPHTHALMITIS; EYE INFECTION; EYE SURGERY; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; RANDOMIZED CONTROLLED TRIAL; RETROBULBAR ANESTHESIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS LUGDUNENSIS; STREPTOCOCCUS MITIS; TECHNIQUE;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIBIOTIC PROPHYLAXIS; AQUEOUS HUMOR; BACTERIA; BIOLOGICAL AVAILABILITY; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; HALF-LIFE; HUMANS; MALE; MIDDLE AGED; PHACOEMULSIFICATION; POVIDONE-IODINE; VANCOMYCIN;

EID: 0035119912     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00651-6     Document Type: Article

References (33)

1. Kattan HM, Flynn HW Jr, Pflugfelder SC, Robertson C, Forster RK. Nosocomial endophthalmitis survey: current incidence of infection after intraocular surgery. Ophthalmology 1991;98:227-238.
2. Javitt JC, Vitale S, Canner JK, et al. National outcomes of cataract extraction, endophthalmitis following inpatient surgery. Arch Ophthalmol 1991;109:1085-1089.
3. Fisch A, Salvanet A, Prazuck T, et al. Epidemiology of infective endophthalmitis in France. Lancet 1991;338:1373-1376.
4. Masket S, editor, Consultation section, J Cataract Refract Surg 1993;19:108-111.
5. Apt L, Isenberg SJ, Yoshimori R, et al. The effect of povidone iodine solution applied at the conclusion of ophthalmic surgery. Am J Ophthalmol 1995;119:701-705.
6. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 1991;98:1769-1775.
7. Gills JP. Filter and antibiotics in irrigating solution for cataract surgery. J Cataract Refract Surg 1991;17:385.
8. Samad A, Solomon LO, Milier MA, Mendelson J. Anterior chamber contamination after uncomplicated phacoemulsification and intraocular lens implantation. Am J Ophthalmol 1995;120:143-150.
9. Egger SF, Huber-Spitzy V, Schoida C, Schneider B, Grabner G. Bacterial contamination during extracapsular cataract extraction: prospective study of 200 consecutive patients. Ophthalmol 1994;208:77-81.
10. Henry JC, Rozas D, Bryant E, Memphis W. Bacterial growth from anterior chamber fluid aspirates using different irrigating solutions in phacoemulsification [abstract]. Invest Ophthalmol Vis Sci 1993;34:884A.
11. Dickey JO, Thompson KD, Jay WM. Anterior chamber aspirate cultures after uncomplicated cataract surgery. Am J Ophthalmol 1991;112:278-282.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards; 1994 Document M 100-S5; fifth informational supplement.
13. Ormerod LD, Ho DD, Becker LE. Endophthalmitis caused by the coagulase-negative staphylococci. Ophthalmology 1993; 100:715-723.
14. Pflugfelder SC, Hernández E, Fliesler SJ. Intravitreal vancomycin: retinal toxicity, clearance, and interaction with gentamicin. Arch Ophthalmol 1987;105:831-837.
15. Pulido JS, Shires TK, Flynn HW Jr. Intravitreal aminoglycosides toxicity revisited. Arch Ophthalmol 1992;110:107-112.
16. Gritz OC, Cevallos AV, Smolin G, Whitcher JP. Antibiotic supplementation of intraoperative infusions: an in vitro model. ARVO abstracts. Invest Ophthalmol Vis Sci 1995; 36(suppl):154.
17. Pflugfelder SC, Hernández E, Filesier SJ, Alvarez J, Pflugfelder ME, Forster RK. Intravitreal vancomycin: retinal toxicity, clearance, and interaction with gentamicin. Arch Ophthalmol 1987;105:831-837.
18. Starr MB, Rally JM. Antimicrobial prophylaxis for ophthalmic stirgery. Surv Ophthalmol 1995;39:485-501.
19. Pospisil A, Pospisil F, Dupont MJ, Delbosc B, Montard M. Contamination bactérienne de la chambre antérieure et chirurgie de la catarata. J Fr Ophthalmol 1993;16:10-13.
20. Chisholm IA, Griefson I. Particulate phagocytosis by trabecular meshwork endothelium. Can J Ophthalmol 1977;12: 293-299.
21. Sen DK, Sarin GS, Saba K. Immunoglobulins in human aqueous humor. Br J Ophthalmol 1977;61:216-217.
22. Dickey JO, Thompson KD, Jay WM. Intraocular gentamicin sulfeto and postcataract anterior chamber aspirate cultures. J Cataract Refract Surg 1994;20:373-377.
23. Donahue SP, Kowalski RP, Eller AW, DeVaro JM, Jewart BH. Empiric treatment of endophthalmitis: are aminiglycosides necessary? Arch Ophthalmol 1994;112:45-47.
24. Roberts CW, Akiyama R, Koniarek JP, Kuang K, Fischberg J. Intraocular miotics and the corneal endothelium. In: Cangelosi GC, editor. Advances in cataract surgery. Thorofare, New Jersey: Slack, 1991:157-166.
25. Apt L, Isenberg SJ, Yoshimori R, Spierer A. Outpatient topical use of povidone-iodine in preparing the eye for surgery. Ophthalmology 1989;96:289-292.
26. Classen DC, Evans RS, Pestontnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 1992;326:281-286.
27. Miller JM, Holmes HT. Specimen collection, transport and storage. In: Murray PR, editor. Manual of clinical microbiology. 6th ed. Washington: American Society for Microbiology, 1995;20:19-32.
28. Beyer TL, Vogler G, Sharma D, O'Donnell FE. Protective barrier effect on the posterior lens capsule in exogenous bacterial endophthalmitis: an experimental primate study. Invest Ophthalmol Vis Sci 1984;25:108-116.
29. Beyer TL, O'Donnell FE, Goncalves V, Singh R. Role of posterior capsule in the prevention of postoperative bacterial endophthalmitis: experimental primate study and clinical implications. Br J Ophthalmol 1985;69:841-849.
30. Teichmann KD. Antibacterial concentrations [letter]. J Cataract Refract Surg 1993;19:446.
31. Hospital Infection Control Practices Advisory Committee (HICAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16:105-113.
32. Fiscella RG. Vancomycin use in ophthalmology. Arch Ophthalmol 1995;113:1353-1354.
33. Alfonso EC, Flynn HW Jr. Controversies in endophthalmitis prevention: the risk for emerging resistance to vancomycin. Arch Ophthalmol 1995;113:1369-1370.